FDA proposes removal of common decongestant. Story by Lesya Feinstein • 4w. H UNTINGTON, W.Va. (WSAZ) - The US Food and Drug Administration announced a proposal to remove a popular ingredient in ...

Nov. 7 (UPI) --The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants. "It ...

The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.

Currently, oral phenylephrine is widely used as a nasal decongestant active ingredient. (Image Credits: Pixabay) The U.S. Food and D rug Administration (USFDA) on Friday announced that it is ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights, opens new tab ...

The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an ...

The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy medications – oral phenylephrine. The active ingredient is used in over-the ...

The FDA is now seeking public comments on this proposed order. For now, companies may continue to market drug products containing oral phenylephrine as a nasal decongestant.

FDA proposes removal of common decongestant. The FDA is moving to pull a decongestant from store shelves. By Lesya Feinstein. Published: Nov. 27, 2024 at 10:37 AM EST HUNTINGTON ...

FDA says commonly used decongestant 'not effective,' proposes removal. Mike Heuer. Thu, November 7, 2024 at 7:52 PM UTC. 2 min read.

FDA officials said an agency review of the available data found ... FDA proposes removing ineffective decongestant found in most cold medicine by Nathaniel Weixel - 11/07/24 2:28 PM ET.